0000899243-22-023139.txt : 20220617
0000899243-22-023139.hdr.sgml : 20220617
20220617171232
ACCESSION NUMBER: 0000899243-22-023139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sigal Nolan Howard
CENTRAL INDEX KEY: 0001323291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 221024974
MAIL ADDRESS:
STREET 1: 941 BERRY AVENUE
CITY: LOS ALTOS
STATE: CA
ZIP: 94024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-15
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001323291
Sigal Nolan Howard
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
1
0
0
0
Stock Option (right to buy)
0.397
2022-06-15
4
A
0
54500
0.00
A
2032-06-14
Common Stock
54500
54500
D
This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders.
/s/ Manuel Aivado, attorney-in-fact for Nolan Howard Sigal
2022-06-16